Janus Henderson Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,537
| Closed | -$68.3K | – | 2580 |
|
|
2023
Q2 | $68.3K | Sell |
2,537
-4
| -0.2% | -$108 | ﹤0.01% | 2581 |
|
|
2023
Q1 | $148K | Buy |
2,541
+1,728
| +213% | +$101K | ﹤0.01% | 2562 |
|
|
2022
Q4 | $41.5K | Sell |
813
-813
| -50% | -$41.5K | ﹤0.01% | 2428 |
|
|
2022
Q3 | $132K | Buy |
1,626
+811
| +100% | +$65.8K | ﹤0.01% | 2462 |
|
|
2022
Q2 | $55K | Buy |
815
+4
| +0.5% | +$270 | ﹤0.01% | 2546 |
|
|
2022
Q1 | $90K | Hold |
811
| – | – | ﹤0.01% | 2576 |
|
|
2021
Q4 | $78K | Buy |
+811
| New | +$78K | ﹤0.01% | 2519 |
|
|
2020
Q2 | – | Sell |
-216,855
| Closed | -$62.5M | – | 1351 |
|
|
2020
Q1 | $62.5M | Buy |
+216,855
| New | +$62.5M | 0.04% | 393 |
|